Principal Financial Group
CRSP icon

Principal Financial Group’s CRISPR Therapeutics CRSP Stock Holding History

Principal Financial Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,771
Closed -$374K – 2205
2025
Q3 		$374K Buy
5,771
+104
+2% +$5.97K ﹤0.01% 2100
2025
Q2 		$276K Buy
+5,667
New +$219K ﹤0.01% 2089
2024
Q3 		– Sell
-7,052
Closed -$381K – 2268
2024
Q2 		$381K Sell
7,052
-33,418
-83% -$1.93M ﹤0.01% 2016
2024
Q1 		$2.76M Buy
+40,470
New +$2.9M ﹤0.01% 1729
2022
Q4 		– Sell
-9,059
Closed -$592K – 2462
2022
Q3 		$592K Buy
9,059
+265
+3% +$19.2K ﹤0.01% 1927
2022
Q2 		$534K Sell
8,794
-21
-0.2% -$1.24K ﹤0.01% 2044
2022
Q1 		$553K Sell
8,815
-344
-4% -$21.6K ﹤0.01% 2093
2021
Q4 		$694K Sell
9,159
-6,043
-40% -$528K ﹤0.01% 2051
2021
Q3 		$1.7M Sell
15,202
-2,427
-14% -$305K ﹤0.01% 1899
2021
Q2 		$2.85M Buy
17,629
+1,875
+12% +$228K ﹤0.01% 1836
2021
Q1 		$1.92M Buy
+15,754
New +$2.38M ﹤0.01% 1862

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GP
GSK plc London $599M AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return